SMV Pharmaceuticals Private Limited
About SMV Pharmaceuticals Private Limited
Data last updated:
SMV Pharmaceuticals Private Limited is a private limited company based in Chandigarh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 May 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U51909CH2021PTC043677.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1.34 Lakh. It is led by directors Vivek Verma and Siddharth Bhardwaj.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SCO 139 – 140 Sector 9C, Chandigarh, India – 160009.
As per the financials filed for FY 2025, the company reported a revenue of ₹42.95 Lakh, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹1.37 Lakh (net margin 3.2%) and EBITDA of ₹3.48 Lakh (EBITDA margin 8.1%). Revenue has grown at a compounded annual rate (CAGR) of 31% over three years.
Company details
Contact details
SMV Pharmaceuticals Private Limited's registered office is in Chandigarh, Chandigarh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSCO 139 – 140 Sector 9C, Chandigarh, India – 160009
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of SMV Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of SMV Pharmaceuticals are trade and support service to organizations. In detail, this covers wholesale trading and other support services to organizations. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | |
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of SMV Pharmaceuticals Private Limited, buy the company report.
Financials of SMV Pharmaceuticals Private Limited
FY 2025 filings availableSMV Pharmaceuticals Private Limited reported revenue of ₹42.95 Lakh (up 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 31% over three years, including 2% growth in the latest year. EBITDA fell 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹3.48 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹1.37 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 8.1% | |||
| Net Profit Margin | 3.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of SMV Pharmaceuticals Private Limited, buy the company report.
Board of directors of SMV Pharmaceuticals Private Limited
SMV Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vivek Verma Also directs: Meilleur Advisors Private Limited | Director | 19 May 2021 | 5 Years 5 Months | Current |
| Siddharth Bhardwaj Also directs: Meilleur Advisors Private Limited, Kuldip Prakash & Sons LLP, City Enterprises Private Limited and 1 more | Director | 19 May 2021 | 5 Years 5 Months | Current |
Peer comparison
SMV Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Induct Pharmaceuticals Private Limited | ₹43.2 Lakh (FY 2025) | -17.0% | Surat, Gujarat, India | |||
| Amare Cor Pharmaceuticals Private Limited | ₹43.06 Lakh (FY 2024) | -4.0% | Ranchi, Jharkhand, India | |||
| SMV Pharmaceuticals Private Limitedthis company | ₹42.95 Lakh (FY 2025) | ₹1.37 Lakh | 3.2% | 2.0% | Chandigarh, India | |
| Arlics Pharmaceuticals Private Limited | ₹42.92 Lakh (FY 2025) | 1.0% | Mehsana, Gujarat, India | |||
| Torrey Pharmaceuticals Private Limited | ₹42.92 Lakh (FY 2024) | 116.0% | Nagpur, Maharashtra, India | |||
| Denexo Pharmaceuticals Private Limited | ₹42.9 Lakh (FY 2025) | 4.0% | Kharghar, Maharashtra, India | |||
| Trumedis Pharmaceuticals Private Limited | ₹42.85 Lakh (FY 2025) | 0.0% | New Delhi, Delhi, India | |||
| Wevet Pharmaceuticals Private Limited | ₹42.84 Lakh (FY 2024) | 69.0% | Allahabad, Uttar Pradesh, India |
To see the full peer comparison of SMV Pharmaceuticals Private Limited, buy the company report.
Auditor
SMV Pharmaceuticals Private Limited is audited by SANJEEV SHARMA AND ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANJEEV SHARMA AND ASSOCIATES | FY 2024 | 012326N |
Shareholding
The shareholding of SMV Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of SMV Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving SMV Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for SMV Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
SMV Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 02, 2024.
GST
No GST registration is on our record for SMV Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
SMV Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Siddharth Bhardwaj was appointed as Director on 19 May 2021.
Frequently asked questions
SMV Pharmaceuticals is an active private limited company based in Chandigarh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 May 2021 (5+ years old) and is registered under CIN U51909CH2021PTC043677.
SMV Pharmaceuticals has 2 current directors:
- Vivek Verma - Director
- Siddharth Bhardwaj - Director
The latest financial statements of SMV Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of SMV Pharmaceuticals is U51909CH2021PTC043677. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
SMV Pharmaceuticals was incorporated on 19 May 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of SMV Pharmaceuticals by revenue are Induct Pharmaceuticals Private Limited, Amare Cor Pharmaceuticals Private Limited, Arlics Pharmaceuticals Private Limited, Torrey Pharmaceuticals Private Limited, Denexo Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Siddharth Bhardwaj was appointed as Director on 19 May 2021. Vivek Verma was appointed as Director on 19 May 2021.
The registered office of SMV Pharmaceuticals is at SCO 139 – 140 Sector 9C, Chandigarh, India – 160009.
SMV Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
SMV Pharmaceuticals can be reached at its registered office: SCO 139 – 140 Sector 9C, Chandigarh, India – 160009.
SMV Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Chandigarh.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
